| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 26,306 | 25,124 | 25,331 | 26,796 | | Cost of Revenue | 6,142 | 7,022 | 7,304 | 7,984 | | | Gross Profit |
-
| 18,102 | 18,027 | 18,812 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,552 | 13,784 | 11,083 | 10,653 | | Non Recurring |
-
|
-
| 49,501 |
-
| | Others | 6,000 | 6,000 | 4,000 | 2,360 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (1,682) | (46,557) | 5,799 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,612 | (1,682) | (46,557) | 5,799 | | Interest Expense | 2,726 | 2,850 | 2,981 | 3,475 | | Income Before Tax | (1,114) | (4,532) | (49,538) | 2,324 | | Income Tax Expense | (683) | (1,845) | (214) | 766 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (431) | (2,687) | (49,324) | 1,558 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (431) | (2,687) | (49,324) | 1,558 | | Preferred Stock And Other Adjustments | (621) | (1,260) |
-
| (185) | | | Net Income Applicable To Common Shares | ($1,052) | ($3,947) | ($49,324) | $1,373 |
|
0.83% Nasdaq 0.00%
Income Statement
